Legis Daily

To provide for the development and dissemination of best practice guidelines for using data collected by prescription drug monitoring programs to identify drug diversion and abuse, and for other purposes.

USA115th CongressHR-6608| House 
| Updated: 7/27/2018
Martha McSally

Martha McSally

Republican Representative

Arizona

Cosponsors (1)
Kevin Cramer (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Prescription Drug Monitoring Program Best Practices Act of 2018 This bill establishes a series of grant programs to support prescription drug monitoring programs (PDMPs), including a grant program to facilitate the adoption of a specified system that allows PDMP data to be shared across states.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 26, 2018
Introduced in House
Jul 26, 2018
Referred to the House Committee on Energy and Commerce.
Jul 27, 2018
Referred to the Subcommittee on Health.
  • July 26, 2018
    Introduced in House
  • July 26, 2018
    Referred to the House Committee on Energy and Commerce.
  • July 27, 2018
    Referred to the Subcommittee on Health.

Health

AppropriationsCongressional oversightDrug, alcohol, tobacco useGovernment studies and investigationsHealth information and medical recordsPrescription drugs

To provide for the development and dissemination of best practice guidelines for using data collected by prescription drug monitoring programs to identify drug diversion and abuse, and for other purposes.

USA115th CongressHR-6608| House 
| Updated: 7/27/2018
Prescription Drug Monitoring Program Best Practices Act of 2018 This bill establishes a series of grant programs to support prescription drug monitoring programs (PDMPs), including a grant program to facilitate the adoption of a specified system that allows PDMP data to be shared across states.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 26, 2018
Introduced in House
Jul 26, 2018
Referred to the House Committee on Energy and Commerce.
Jul 27, 2018
Referred to the Subcommittee on Health.
  • July 26, 2018
    Introduced in House
  • July 26, 2018
    Referred to the House Committee on Energy and Commerce.
  • July 27, 2018
    Referred to the Subcommittee on Health.
Martha McSally

Martha McSally

Republican Representative

Arizona

Cosponsors (1)
Kevin Cramer (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AppropriationsCongressional oversightDrug, alcohol, tobacco useGovernment studies and investigationsHealth information and medical recordsPrescription drugs